Morishita Kae, Kyo Chika, Yonemoto Takako, Kosugi Rieko, Ogawa Tatsuo, Inoue Tatsuhide
Center for Diabetes, Endocrinology and Metabolism, Shizuoka General Hospital, No. 4-27-1, Kita-Ando, Aoi-ku, Shizuoka, Shizuoka 420-8527, Japan.
Case Rep Endocrinol. 2017;2017:4709262. doi: 10.1155/2017/4709262. Epub 2017 Jan 9.
Congenital hyperinsulinism (CHI) caused by a glucokinase- (GCK-) activating mutation shows autosomal dominant inheritance, and its severity ranges from mild to severe. A 43-year-old female with asymptomatic hypoglycemia (47 mg/dL) was diagnosed as partial adrenal insufficiency and the administration of hydrocortisone (10 mg/day) was initiated. Twelve years later, her 8-month-old grandchild was diagnosed with CHI. Heterozygosity of exon 6 c.590T>C (p.M197T) was identified in a gene analysis of GCK, which was also detected in her son and herself. The identification of GCK-activating mutations in hyperinsulinemic hypoglycemia patients may be useful for a deeper understanding of the pathophysiology involved and preventing unnecessary glucocorticoid therapy.
由葡萄糖激酶(GCK)激活突变引起的先天性高胰岛素血症(CHI)呈常染色体显性遗传,其严重程度从轻度到重度不等。一名43岁无症状低血糖(47mg/dL)女性被诊断为部分肾上腺功能不全,并开始给予氢化可的松(10mg/天)治疗。12年后,她8个月大的孙子被诊断为CHI。在GCK基因分析中发现外显子6 c.590T>C(p.M197T)杂合性,在她儿子和她自己身上也检测到了该突变。在高胰岛素血症低血糖患者中鉴定GCK激活突变可能有助于更深入了解其中涉及的病理生理学,并避免不必要的糖皮质激素治疗。